Mo Reza Ebrahimkhani

Title: Mo Reza Ebrahimkhani: Innovator in Synthetic Liver Organoids and Gene Therapy

Introduction

Mo Reza Ebrahimkhani is a prominent inventor based in Pittsburgh, PA (US). He has made significant contributions to the fields of synthetic biology and gene therapy, holding a total of 7 patents. His work focuses on developing innovative solutions for drug discovery and human liver modeling.

Latest Patents

Ebrahimkhani's latest patents include groundbreaking advancements such as "Next Generation Designer Liver Organoids and Their Methods of Preparation and Use." This patent relates to synthetic liver organoids and outlines methods for utilizing these organoids in various applications, including drug discovery and modeling human liver development. Another notable patent is "Modulating Human Cas9-Specific Host Immune Response," which provides methods and compositions aimed at reducing undesirable T cell immune responses in patients undergoing gene therapy using CRISPR/Cas9-based genetic modulation.

Career Highlights

Throughout his career, Ebrahimkhani has worked with esteemed institutions such as Arizona State University and The Johns Hopkins University. His research has significantly advanced the understanding and application of synthetic organoids in medical science.

Collaborations

Ebrahimkhani has collaborated with notable colleagues, including Samira Kiani and Farzaneh Moghadam. Their joint efforts have contributed to the development of innovative techniques in the field of gene therapy and synthetic biology.

Conclusion

Mo Reza Ebrahimkhani is a leading figure in the innovation of synthetic liver organoids and gene therapy. His patents and collaborations reflect his commitment to advancing medical science and improving therapeutic strategies.